INCIDENCE AND SIGNIFICANCE OF TUMOR EGFR AND KRAS MUTATIONS IN GREEK METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH 1ST LINE CHEMOTHERAPY

被引：0
|
作者：
Linardou, Helena [1 ]
Pectasides, Dimitrios [1 ]
Agelaki, Sophia [1 ]
Kotoula, Vassiliki [1 ]
Karavasilis, Vasilios [1 ]
Eleftheraki, Anastasia G. [1 ]
Samantas, Epaminondas [1 ]
Kotsakis, Athanasios [1 ]
Razis, Evangelia [1 ]
Fountzilas, George [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
KRAS; EGFR; mutations; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.06-057
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [1] Evaluation of the prognostic/predictive role of tumor EGFR and KRAS mutations in Greek metastatic non-small cell lung cancer patients treated with first-line chemotherapy
    Linardou, Helena
    Kosmidis, Paris A.
    Kotoula, Vassiliki
    Karavasilis, Vasilios
    Eleftheraki, Anastasia G.
    Lazaridis, Georgios
    Daskalaki, Emily
    Lakis, Sotiris
    Charalambous, Elpida
    Samantas, Epaminontas
    Pectasides, Dimitrios G.
    Bafaloukos, Dimitris
    Fountzilas, George
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment
    Linardou, Helena
    Kotoula, Vassiliki
    Kouvatseas, George
    Mountzios, Giannis
    Karavasilis, Vasilios
    Samantas, Epaminondas
    Kalogera-Fountzila, Anna
    Televantou, Despina
    Papadopoulou, Kyriaki
    Mavropoulou, Xanthipi
    Daskalaki, Emily
    Zaramboukas, Thomas
    Efstratiou, Ioannis
    Lampaki, Sofia
    Rallis, Grigorios
    Res, Eleni
    Syrigos, Konstantinos N.
    Kosmidis, Paris A.
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. CANCER GENOMICS & PROTEOMICS, 2019, 16 (06) : 531 - 541
  • [3] CLINICOPATHOLOGICAL FEATURES IN NON-SMALL CELL LUNG CANCER PATIENTS WITH EGFR AND KRAS MUTATIONS
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Ito, Hiroyuki
    Watanabe, Masato
    Imamura, Naoko
    Isaka, Tetsuya
    Imai, Kentaro
    Karino, Fumi
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Nakayama, Haruhiko
    Masuda, Munetaka
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S965 - S965
  • [4] Mutations of EGFR and KRAS Genes in Belorussian Patients With Non-Small Cell Lung Cancer
    Mikhalenka, Alena
    Shchayuk, Anna
    Krupnova, Evelina
    Shapetska, Michael
    Chebotaryova, Natalia
    Pissarchik, Svetlana
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S509 - S510
  • [5] EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Serdjebi, Cindy
    Khobta, Nataliya
    Metellus, Philippe
    Ouafik, L'Houcine
    Nanni, Isabelle
    Greillier, Laurent
    Loundou, Anderson
    Fina, Frederic
    Mascaux, Celine
    Barlesi, Fabrice
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
  • [6] EGFR and KRAS Mutational Status and Significance in Greek Patients with Advanced Non Small Cell Lung Cancer
    Linardou, H.
    Kotoula, V.
    Kouvatseas, G.
    Karavasilis, V.
    Mountzios, G.
    Samantas, E.
    Kalogera-Fountzila, A.
    Televantou, D.
    Papadopoulou, K.
    Mavropoulou, X.
    Daskalaki, E.
    Zaramboukas, T.
    Efstratiou, I.
    Lambaki, S.
    Rallis, G.
    Res, E.
    Syrigos, K.
    Kosmidis, P.
    Pectasides, D.
    Fountzilas, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S890 - S890
  • [7] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    [J]. MEDICAL ONCOLOGY, 2014, 31 (08)
  • [8] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    [J]. Medical Oncology, 2014, 31
  • [9] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    R. B. Verheijen
    T. T. van Duijl
    M. M. van den Heuvel
    D. Vessies
    M. Muller
    J. H. Beijnen
    J. M. Janssen
    J. H. M. Schellens
    N. Steeghs
    D. van den Broek
    A. D. R. Huitema
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 269 - 276
  • [10] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    Verheijen, R. B.
    van Duijl, T. T.
    van den Heuvel, M. M.
    Vessies, D.
    Muller, M.
    Beijnen, J. H.
    Janssen, J. M.
    Schellens, J. H. M.
    Steeghs, N.
    van den Broek, D.
    Huitema, A. D. R.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 269 - 276
12345